ATA53492A - Verwendung von ciclosporin zur pulmonalen verabreichung - Google Patents

Verwendung von ciclosporin zur pulmonalen verabreichung

Info

Publication number
ATA53492A
ATA53492A AT0053492A AT53492A ATA53492A AT A53492 A ATA53492 A AT A53492A AT 0053492 A AT0053492 A AT 0053492A AT 53492 A AT53492 A AT 53492A AT A53492 A ATA53492 A AT A53492A
Authority
AT
Austria
Prior art keywords
ciclosporin
pulmonal administration
pulmonal
administration
Prior art date
Application number
AT0053492A
Other languages
English (en)
Other versions
AT404553B (de
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Priority to AT31798A priority Critical patent/ATA31798A/de
Publication of ATA53492A publication Critical patent/ATA53492A/de
Application granted granted Critical
Publication of AT404553B publication Critical patent/AT404553B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0053492A 1991-03-18 1992-03-17 Verwendung von ciclosporin zur pulmonalen verabreichung AT404553B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT31798A ATA31798A (de) 1991-03-18 1998-02-23 Pharmazeutische zusammensetzung enthaltend ciclosporin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105705A GB9105705D0 (en) 1991-03-18 1991-03-18 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
ATA53492A true ATA53492A (de) 1998-05-15
AT404553B AT404553B (de) 1998-12-28

Family

ID=10691762

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0053492A AT404553B (de) 1991-03-18 1992-03-17 Verwendung von ciclosporin zur pulmonalen verabreichung

Country Status (29)

Country Link
US (1) US5719123A (de)
EP (1) EP0504760B1 (de)
JP (1) JP2549794B2 (de)
KR (1) KR920017644A (de)
AT (1) AT404553B (de)
AU (1) AU658172B2 (de)
CA (1) CA2063106C (de)
CH (1) CH685229A5 (de)
CZ (1) CZ281260B6 (de)
DE (1) DE4208258B4 (de)
DK (1) DK0504760T3 (de)
ES (1) ES2093130T3 (de)
FI (1) FI921125A (de)
FR (1) FR2674249A1 (de)
GB (2) GB9105705D0 (de)
GR (1) GR3021497T3 (de)
HU (1) HU208492B (de)
IE (1) IE67627B1 (de)
IL (1) IL101244A (de)
IT (1) IT1255040B (de)
LU (1) LU88087A1 (de)
MX (1) MX9201141A (de)
NO (1) NO310754B1 (de)
NZ (1) NZ241975A (de)
RU (1) RU2098122C1 (de)
SA (1) SA92120536B1 (de)
SK (1) SK279576B6 (de)
TW (1) TW215901B (de)
ZA (1) ZA921987B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837677B2 (ja) * 1981-01-13 1983-08-17 松下電器産業株式会社 誘導加熱調理器
JPH07111905B2 (ja) * 1987-07-23 1995-11-29 株式会社東芝 誘導加熱調理器の負荷適否検知回路
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
EP0914143A1 (de) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medizinische aerosollösungsformulierungen mit cyclosporin-a
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
FI20002217A (fi) * 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
JP2005506990A (ja) * 2001-10-19 2005-03-10 アイソテクニカ インコーポレーテッド 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート
WO2004069223A2 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical compositions comprising immunosuppressants and uses thereof
EP1610878B1 (de) * 2003-02-21 2014-09-03 University Of Bath Verfahren zur herstellung von teilchen
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20060078622A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
JP6163482B2 (ja) * 2011-05-27 2017-07-12 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンａの結晶形態、その調製方法、およびその使用のための方法
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
JP6204921B2 (ja) * 2011-11-15 2017-09-27 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンａの形態２およびその作製方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
CH679119A5 (de) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
HUT61324A (en) 1992-12-28
GB9205554D0 (en) 1992-04-29
DE4208258B4 (de) 2007-07-12
IE920839A1 (en) 1992-09-23
US5719123A (en) 1998-02-17
KR920017644A (ko) 1992-10-21
CZ281260B6 (cs) 1996-07-17
FI921125A (fi) 1992-09-19
RU2098122C1 (ru) 1997-12-10
FI921125A0 (fi) 1992-03-16
GB9105705D0 (en) 1991-05-01
NZ241975A (en) 1994-04-27
EP0504760A1 (de) 1992-09-23
FR2674249B1 (de) 1995-05-12
IL101244A (en) 1996-10-31
CA2063106C (en) 2002-12-17
HU9200735D0 (en) 1992-05-28
NO921012L (no) 1992-09-21
AT404553B (de) 1998-12-28
NO921012D0 (no) 1992-03-16
ITRM920181A0 (it) 1992-03-17
JPH0585940A (ja) 1993-04-06
DK0504760T3 (da) 1996-12-23
ZA921987B (en) 1993-09-20
IL101244A0 (en) 1992-11-15
GB2253853A (en) 1992-09-23
JP2549794B2 (ja) 1996-10-30
TW215901B (de) 1993-11-11
SK279576B6 (sk) 1999-01-11
NO310754B1 (no) 2001-08-27
CH685229A5 (de) 1995-05-15
HU208492B (en) 1993-11-29
MX9201141A (es) 1992-10-01
CS78592A3 (en) 1992-10-14
IE67627B1 (en) 1996-04-17
FR2674249A1 (fr) 1992-09-25
ITRM920181A1 (it) 1993-09-17
DE4208258A1 (de) 1992-09-24
CA2063106A1 (en) 1992-09-19
GR3021497T3 (en) 1997-01-31
EP0504760B1 (de) 1996-10-09
SA92120536B1 (ar) 2005-04-27
LU88087A1 (fr) 1993-10-27
GB2253853B (en) 1995-04-26
ES2093130T3 (es) 1996-12-16
AU658172B2 (en) 1995-04-06
AU1294092A (en) 1992-09-24
IT1255040B (it) 1995-10-13

Similar Documents

Publication Publication Date Title
ATA53492A (de) Verwendung von ciclosporin zur pulmonalen verabreichung
DE69220382D1 (de) Verwendung von Peptidderivaten
DE69130246D1 (de) System zur Bildung von Sätzen
DE59207032D1 (de) Wirbelkörperimplantat
DK22588A (da) Peptidderivater
DK61691D0 (da) Genetiske konstruktioner
DE69119539D1 (de) Ersetzung von Hauptleitungen
FI89097C (fi) Matningsbomanordning vid bergsborr
DE69226763D1 (de) Härten von fluoroelastomeren
DE59209936D1 (de) Verwendung von Acetalen
ATE198275T1 (de) Subkutane implantate bestehend aus nomgestrolderivaten
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
FI935135A0 (fi) Foerfarande foer rening av TiO2-malm
DE3887904D1 (de) Nachräumer zur bohrlocherweiterung.
ATA81591A (de) Wirbelkoerperimplantat
DK4390A (da) Peptidderivater
FR2629338B1 (fr) Implant femoro-rotulien
FI942467A0 (fi) Proteesivakaat proteiinit
DE69228669D1 (de) Proteinsequenzierung
KR930013140U (ko) 코 보형물(nasal implant)
DE69218215D1 (de) Entfernung von schwefelwasserstoff
DK679488A (da) Peptidderivater
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
IT8922436A0 (it) Testata tattica
KR930026760U (ko) Tvcr의 개선된 구성

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
MK07 Expiry

Effective date: 20120317